Skip to main content
. Author manuscript; available in PMC: 2010 Jul 18.
Published in final edited form as: Ann Rheum Dis. 2008 Oct 1;68(9):1461–1465. doi: 10.1136/ard.2008.096834

Table 3.

Bone marrow lesion and cartilage status in subregions at 30-month follow-up

Cartilage status at
30-month follow-up
in subregions		 Stable BMLs
(n = 151; 34.3%)		 Decrease of BMLs
(n = 41; 9.3%)		 Resolution of BMLs
(n = 178; 40.5%)		 Progression of BMLs
(n = 70; 15.9%)		 No BML at baseline and
follow-up
(n = 4687; 96.3%)		 New BMLs
(n = 182; 3.7%)
Increase in cartilage
score, n (%)		 41 (27.2) 12 (29.3) 50 (28.1) 36 (51.4) 281 (6.0) 101 (55.5)
Adjusted* OR of
cartilage loss
(95% CI)		   1.0 (Reference)   1.2 (0.5 to 1.6)   0.9 (0.5 to 1.6)   2.8 (1.5 to 5.2)     0.2 (0.1 to 0.3)     3.5 (2.1 to 5.9)
*

Adjusted for gender, age, body mass index and Kellgren and Lawrence grade at baseline.

BML, bone marrow lesion; 95% CI, 95% confidence interval; OR, odds ratio.